Ex Parte Paul et al - Page 2


                 Appeal No.  2006-2037                                                          Page 2                  
                 Application No.  10/414,938                                                                            
                 Accordingly, claims 1-4, 6-11, 15-18, and 20-24 are before us on appeal.                               
                 Claim 1 is illustrative of the subject matter on appeal and is reproduced below:                       
                        1.  A medical device for at least partial implantation, comprising:                             
                                   a main body having a first end, a second end, and a lumen                            
                            extending therebetween,                                                                     
                                   a first section proximal the first end of said main body and                         
                            having a first therapeutic agent, said first therapeutic agent comprising                   
                            one or more members selected from the group consisting of                                   
                            antiproliferatives, anticoagulants, antithrombotics, thrombolytics, and                     
                            fibrinolytics; and                                                                          
                                   a second section proximal the second end of said main body                           
                            and having a second therapeutic agent, said second therapeutic agent                        
                            comprising an antimicrobial;                                                                
                                   said main body having a length such that when said device is at                      
                            least partially implanted said first end accesses a body vessel and at                      
                            least a portion of said second section is disposed within a                                 
                            subcutaneous space of a patient.                                                            
                        The references relied upon by the examiner are:                                                 
                 Ragheb et al. (Ragheb)  6,299,604   Oct.   9, 2001                                                     
                 Pacetti et al. (Pacetti)  6,663,662   Dec. 16, 2003                                                    
                                                                   (102(e) date Dec. 28, 2000)                          

                                             GROUNDS OF REJECTION                                                       
                        Claims 1, 2, 15, 18, and 20-24 stand rejected under 35 U.S.C. § 102(b) as                       
                 anticipated by Ragheb.                                                                                 
                        Claims 1, 3, 4, 6, 7, 10, 11, 15, 16, and 20-24 1 stand rejected under                          
                 35 U.S.C. § 102(e) as anticipated by Pacetti.                                                          
                        Claims 8, 9, and 18 stand rejected under 35 U.S.C. § 103 as being                               
                 unpatentable over Pacetti.                                                                             
                        We reverse.                                                                                     

                                                                                                                        
                 1 The examiner included claim 5 in this rejection.  However, as appellants emphasize (Reply            
                 Brief, page 2), claim 5 was previously cancelled.                                                      




Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  Next

Last modified: September 9, 2013